Clinical Cancer Research publishes articles that focus on innovative clinical and translational research bridging the laboratory and the clinic. Topics include targeted therapies; mechanisms of drug ...

Cancer Immunology Research publishes outstanding original articles reporting major advances in cancer immunology that span the discipline from basic investigations in host-tumor interactions to ...

Melissa R. Perrino; Anirban Das; Sarah R. Scollon; Sarah G. Mitchell; Mary-Louise C. Greer; Marielle E. Yohe; Jordan R. Hansford; Jennifer M. Kalish; Kris Ann P ...

1Centre de Recherche en Cancérologie de Marseille, INSERM U1068, CNRS UMR7258, Aix Marseille Université U105, Institut Paoli Calmettes, Marseille, France. 4Institut Paoli-Calmettes, Marseille, France.

According to research presented at the Society for the Immunotherapy of Cancer Annual Meeting in Houston, TX, the IL15 agonist NKTR-255 (Nektar Therapeutics) reverses lymphopenia caused by ...

1Division of Digestive and Liver Diseases, Department of Medicine, Irving Cancer Research Center Columbia University Medical Center, New York, New York. 2Columbia University Digestive and Liver ...

3Department of Computer Science, Princeton University, Princeton, New Jersey. 1Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York. 6The David M. Rubenstein Center for ...

This open access article is distributed under the Creative Commons Attribution 4.0 International (CC BY 4.0) license. This work is licensed under a Creative Commons Attribution 4.0 International ...

1Department of Hematology, The First Affiliated Hospital of Xiamen University and Institute of Hematology, School of Medicine, Xiamen University, Xiamen, China. 2Key Laboratory of Xiamen for Diagnosis ...

1Department of Immunology, Guizhou Province Key Laboratory for Regenerative Medicine, Clinical Research Center, School of Basic Medicine, Affiliated Hospital of Guizhou Medical University, Guizhou ...

In preliminary results from the phase II iMMagine-1 trial released today, the BCMA-directed chimeric antigen receptor (CAR) T-cell therapy anitocabtagene autoleucel (anito-cel) did not elicit any ...